TipRanks on MSN
GE Healthcare issues $1.25 billion in senior notes
GE Healthcare Technologies Inc ( ($GEHC) ) just unveiled an update. On December 12, 2025, GE Healthcare Technologies Inc. entered into a ...
CHICAGO--(BUSINESS WIRE)--GE HealthCare has topped a U.S. Food and Drug Administration (FDA) list of artificial intelligence (AI) enabled medical devices for the third year in a row with 72 listed 510 ...
Cooper Investors, an investment management firm, released its “Cooper Investors Global Equities Fund (Unhedged)” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The ...
Supporting Wisconsin’s efforts in personalized medicine, GE HealthCare is now manufacturing the company’s latest Omni Legend imaging scanners in Waukesha. Medical imaging is a crucial tool for ...
Two of GE’s high-profile spin-offs, GE Vernova Inc (NYSE:GEV) and GE Healthcare Technologies Inc (NASDAQ:GEHC), are preparing to report their third-quarter earnings, but one seems better positioned ...
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) unveiled three new advanced deep learning image processing and reconstruction solutions as a part of its Effortless Recon DL portfolio at the ...
In the chaos of an emergency room, seconds count. A young patient arrives, showing symptoms that could indicate a life-threatening heart condition. But this rural hospital lacks advanced diagnostic ...
GE HealthCare and Tribun Health collaboration helps foster enterprise imaging and pathology for oncology CHICAGO, ILLINOIS / ACCESS Newswire / December 10, 2025 / GE HealthCare (Nasdaq: GEHC) ...
GE HealthCare is a global company, and trade wars are not good for its competitive positioning in international markets. Tariffs will add to the company's costs, as it sources products from around the ...
GE HealthCare Technologies Inc. GEHC recently used NVIDIA Corporation’s NVDA technology to develop its recent research model, SonoSAMTrack. This builds upon its long-term artificial intelligence (AI) ...
I am initiating GE HealthCare with a 'sell' rating and a fair value of $61, citing tariff headwinds and weak China growth. Despite stable industry positioning and margin improvements, tariff impacts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results